Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
2008
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors
2003
Switch from Efavirenz to Nevirapine Associated with Resolution of Efavirenz-Related Neuropsychiatric Adverse Events and Improvement in Lipid Profiles
2006
Health care-associated infections – an overview
2018 Standout
Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study
2003
Cancer and the ‘other’ noncommunicable chronic diseases in older people living with HIV/AIDS in resource-limited settings
2012
Stroke in patients with human immunodeficiency virus infection
2007
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
2004
Cardiovascular disease in patients with hemophilia
2009
Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population
2008
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
A global view of pulmonary hypertension
2016 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
The burden of non-communicable diseases in South Africa
2009 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era
2009
Increased Platelet and Microparticle Activation in HIV Infection
2011
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
2009
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
2004
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
2009
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
2010
Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
2018
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
The global burden of multiple chronic conditions: A narrative review
2018 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Metabolic Syndrome and Cardiovascular Risk in HIV-Infected Patients with Lipodystrophy
2007
HIV therapy, metabolic syndrome, and cardiovascular risk
2008
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
2007
Prevalence of risk factors for cardiovascular disease in HIV‐infected patients over time: the Swiss HIV Cohort Study
2006
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection
2010
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
2010
Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States
2009
Human immunodeficiency virus per se exerts atherogenic effects
2008
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
2013
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy**The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator.
2005
CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater
2007
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil
2008
HIV infection and cardiovascular disease
2014
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
2018
The interface between stroke and infectious disease: Infectious diseases leading to stroke and infections complicating stroke
2008
Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis
2015
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
2006
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
2006
Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
2009 Standout
Mechanisms of Antibiotic Resistance
2016 Standout
Mitochondrial Dysfunction in Atherosclerosis
2007
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
2007 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Human immunodeficiency virus infection and macrophage cholesterol metabolism
2006
Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria
2006
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
2005
Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection
2018
The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study
2006
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV‐1‐infected individuals receiving combination antiretroviral therapy
2009
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus
2009
Inflammatory Mechanisms in Obesity
2011 Standout
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
The Metabolic Syndrome
2008 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Quinolone 3-Carboxylic Acid Pharmacophore: Design of Second Generation HIV-1 Integrase Inhibitors
2008
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
2009
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
2007
Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial
2008
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
2009
Guidelines for the management of hemophilia
2012 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Hospital Epidemiology and Infection Control in Acute-Care Settings
2011
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of S Mateu being referenced
Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?
2004
Cardio- and cerebrovascular events in HIV-infected persons
2004
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
2003